
Of patients in the atopic dermatitis (AD) cohort, 36.6% developed at least 1 comorbidity amid follow-up compared to 28.5% in the non-AD reference cohort.

Of patients in the atopic dermatitis (AD) cohort, 36.6% developed at least 1 comorbidity amid follow-up compared to 28.5% in the non-AD reference cohort.

Overall, the study authors concluded that the immunogenicity of quadrivalent influenza vaccines (QIV) and trivalent inactivated influenza vaccines (TIV) was similar for common influenza ingredients for children ages 6 to 35 months.

The warning letters issued to 7 manufacturers are part of a larger, ongoing effort by the FDA to address the manufacturing, distribution, and sale of illegal and unauthorized e-cigarettes.

In a systematic and meta-analysis review of cohort studies that featured nearly 1.7 million individuals, study authors concluded that there is an association between high body mass index (BMI) and an increased risk of incident type 1 diabetes.

A child with profound genetic hearing loss was dosed with the investigational otoferlin gene therapy (DB-OTO), becoming the first patient dosed in a phase 1/2 trial evaluating the treatment, and experienced improved auditory response at week 6 with no concerning safety signals.

The MiniMed 780G system has been approved for children aged 7 years and up with type 1 diabetes (T1D), according to Medtronic.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
